Ressources

Researchers have argued that providing genetic explanations of addiction will reduce stigma, but there has been limited research testing this prediction.

Original research | 2023

Stigma

‘We don’t live in a harm reduction world, we live in a prohibition world’: tensions arising in the design of drug alerts

Here, we discuss the tensions that arose in the process of co-designing drug alert templates with health and community workers.

Original research | 2023

Harm reduction, Barriers and enablers, Drug checking, Illegal drugs, Peer/PWLLE program involvement

Investigating the effect of zinc supplementation on probability of relapse and mental health in patients with opioid use disorder undergoing methadone maintenance treatment

The present study aimed to investigate the effect of zinc supplementation on the probability of relapse (PoR) and mental health (MH) problems in patients with opioid use disorder undergoing MMT.

Original research | 2023

Substitution/OAT, Mental health

Faculty, staff, and student perceptions of substance use disorder stigma in health profession training programs: a quantitative study

We aimed to characterize perceptions of faculty, staff, and students about SUD stigma in professional healthcare training programs.

Original research | 2023

About prescribers, Stigma

Understanding the differential effect of local socioeconomic conditions on the relation between prescription opioid supply and drug overdose deaths in US counties

We measured whether the associations of prescription opioid supply with drug overdose deaths vary by local socioeconomic conditions.

Original research | 2023

Overdose, Mortality, Equity

Remote harm reduction services are key solutions to reduce the impact of COVID-19-like crises on people who use drugs: evidence from two independent structures in France and in the USA

The COVID-19 pandemic reduced access to harm reduction (HR) structures in locations undergoing lockdown.

Original research | 2023

Digital health, Harm reduction

Extended-release monthly buprenorphine injection

Guidelines | 2023

Clinical guidance, About prescribers, Substitution/OAT

Safety and feasibility of intranasal heroin-assisted treatment: 4-week preliminary findings from a Swiss multicentre observational study

Heroin-assisted treatment (HAT) is effective for individuals with severe opioid use disorder (OUD) who do not respond sufficiently to other opioid agonist treatments.

Original research | 2023

Safer supply, Evidence base, Barriers and enablers

Transitions in care between hospital and community settings for individuals with a substance use disorder: A systematic review

This review summarizes literature on interventions for optimizing transitions in care from hospital to community for individuals with a substance use disorder (SUD).

Lit review | 2023

Transitions in care/treatment, Hospitals

Substance Use Related Language & Stigma

Slide deck | 2023

Stigma

“The system always undermined what I was trying to do as an individual”: identifying opportunities to improve the delivery of opioid use services for youth from the perspective of service providers in four communities across British Columbia, Canada

It is crucial to ensure that youth using unregulated opioids have access to evidence-based interventions, and yet, youth encounter critical gaps in the quality of such interventions.

Original research | 2023

Youth, Illegal drugs, Barriers and enablers

Access to safer injection equipment among people who inject drugs utilizing medical services in an urban hospital in the United States

This study aimed to characterize how individuals accessing medical care obtain supplies and the impact of perceived barriers to accessing safer injection supplies.

Original research | 2023

Injecting drugs, Barriers and enablers, About PWUD, Harm reduction

Nonfatal opioid-related overdoses treated by emergency medical services in Florida, before and during the COVID-19 pandemic

We assessed changes in nonfatal opioid-related overdoses in Florida during the onset of the COVID-19 pandemic.

Original research | 2023

Overdose

Measuring the preferences of injectable opioid agonist treatment (iOAT) clients: Development of a person-centered scale (best-worst scaling)

Best-worst scaling (BWS) is a preference elicitation method from health economics that has never been applied to addiction care broadly, or iOAT specifically.

Original research | 2023

About PWUD, Substitution/OAT, Barriers and enablers